Exelixis (EXEL) Non-Current Deffered Revenue (2010 - 2023)

Exelixis' (EXEL) quarterly Non-Current Deffered Revenue came in at $6.7 million in Q2 2023, down 6.73% year-on-year from $7.2 million in Q2 2022, and up 6.75% quarter-over-quarter from $6.3 million in Q1 2023.

Exelixis (EXEL) Non-Current Deffered Revenue (2010 - 2023) Analysis & Trends

Exelixis' Non-Current Deffered Revenue history runs 11 years deep, the most recent figure standing at $6.7 million for Q2 2023.

  • On a quarterly basis, Non-Current Deffered Revenue fell 6.73% year-over-year to $6.7 million in Q2 2023; TTM through Jun 2023 was $6.7 million, a 6.73% decrease from a year earlier, with the FY2022 full-year figure at $6.6 million, down 24.68% from the prior year.
  • Non-Current Deffered Revenue rose to $6.7 million in Q2 2023 per EXEL's latest filing, from $6.3 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $16.6 million in Q2 2019 and bottomed at $3.8 million in Q1 2021.
  • The 5-year median for Non-Current Deffered Revenue is $8.4 million (2019), against an average of $9.3 million.
  • Across the five-year window, Non-Current Deffered Revenue soared 579.01% in 2019 and sank 58.51% in 2020, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $15.4 million in 2019, then plunged by 39.47% to $9.3 million in 2020, then slipped by 6.25% to $8.7 million in 2021, then fell by 24.68% to $6.6 million in 2022, then rose by 2.16% to $6.7 million in 2023.
  • Per Business Quant, the three latest EXEL Non-Current Deffered Revenue figures stand at $6.7 million (Q2 2023), $6.3 million (Q1 2023), and $6.6 million (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 6.72 Mn
Mar 31, 2023 6.30 Mn
Dec 30, 2022 6.58 Mn
Sep 30, 2022 6.49 Mn
Jul 1, 2022 7.21 Mn
Apr 1, 2022 8.04 Mn
Dec 31, 2021 8.74 Mn
Oct 1, 2021 9.44 Mn
Jul 2, 2021 8.58 Mn
Apr 2, 2021 9.76 Mn
Jan 1, 2021 3.76 Mn
Oct 2, 2020 9.32 Mn
Jul 3, 2020 15.00 Mn
Apr 3, 2020 14.13 Mn
Jan 3, 2020 6.60 Mn
Sep 27, 2019 15.40 Mn
Jun 28, 2019 16.63 Mn
Mar 29, 2019 8.32 Mn
Dec 28, 2018 15.90 Mn
Sep 28, 2018 2.27 Mn